SCHEMBL22817845

SCHEMBL22817845

c1ccc(-c2ccc(-c3ccc(N(c4ccc(-c5ccccc5)cc4)c4cccc5oc6c7ccccc7c(-c7cccc(-c8ccccc8)c7)cc6c45)cc3)cc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 2/20 0.39
▸ PLA2G2A P14555 3/20 0.36
▸ PLA2G4A P47712 3/20 0.36
▸ PLA2G10 O15496 1/20 0.34
▸ MAPT P10636 2/20 0.32
▸ PRKDC P78527 2/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ GGPS1 O95749 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.31
▸ CDK1 P06493 1/20 0.30
▸ CCNB1 P14635 1/20 0.30
▸ GSK3B P49841 1/20 0.30
▸ CDK5 Q00535 1/20 0.30
▸ CDK5R1 Q15078 1/20 0.30
▸ TNKS O95271 1/20 0.30
▸ EPHX2 P34913 1/20 0.30
▸ CDC14B O60729 1/20 0.30
▸ CDC14A Q9UNH5 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22818002 1.00 ALOX5 (0.39) ALOX5PLA2G2APLA2G4APLA2G10MAPT
SCHEMBL22818356 0.99 ALOX5 (0.38) ALOX5PLA2G2APLA2G4APLA2G10MAPT
SCHEMBL22817687 0.99 ALOX5 (0.38) ALOX5PLA2G2APLA2G4APLA2G10MAPT
SCHEMBL26486655 0.98 ALOX5 (0.37) ALOX5PLA2G2APLA2G4APLA2G10MAPT
SCHEMBL22817846 0.96 ALOX5 (0.36) ALOX5PLA2G2APLA2G4APLA2G10MAPT
SCHEMBL22817832 0.96 ALOX5 (0.36) ALOX5PLA2G2APLA2G4APLA2G10MAPT
SCHEMBL22818003 0.96 ALOX5 (0.36) ALOX5PLA2G2APLA2G4APLA2G10MAPT
SCHEMBL22817733 0.96 ALOX5 (0.36) ALOX5PLA2G2APLA2G4APLA2G10MAPT
SCHEMBL26486654 0.95 ALOX5 (0.36) ALOX5PLA2G2APLA2G4APLA2G10MAPT
SCHEMBL22817696 0.95 ALOX5 (0.37) ALOX5PLA2G2APLA2G4APLA2G10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11812623-B2 Hetero-cyclic compound and organic light emitting device using the same LT MATERIALS CO., LTD. (KR) 2023-11-07 — — US disclosed
US-11812623-B2 Hetero-cyclic compound and organic light emitting device using the same LT MATERIALS CO., LTD. (KR) 2023-11-07 — — US disclosed
US-20200403157-A1 HETERO-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME LT MATERIALS CO., LTD. (KR) 2020-12-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11812623-B2 Hetero-cyclic compound and organic light emitting device using the same CRY1, CRY2, PER2 ALOX5 1385/4885PLA2G2A 4271/4885PLA2G4A 3979/4885
US-20200403157-A1 HETERO-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME CRY1, CRY2, PER2 ALOX5 1385/4885PLA2G2A 4271/4885PLA2G4A 3979/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback